Angiotensin-converting enzyme gene deletion polymorphism modulation of onset of symptoms and survival rate of patients with heart failure

International Journal of Cardiology

Volumn 99, Issue 1, 2005, Pages 97-103

  Cuoco, Marco Antonio Romeo ^a   Pereira, Alexandre Costa ^a   De Freitas, Humberto Felício Gonçalves ^a   Da Mota, Glória De Fátima Alves ^a   Fukushima, Júlia Tizue ^a   Krieger, José Eduardo ^a   Mansur, Alfredo José ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Angiotensin converting enzyme; Heart failure; Polymorphism

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ADOLESCENT; ADULT; AGED; ALCOHOLIC CARDIOMYOPATHY; ANALYSIS OF VARIANCE; ARTICLE; CHAGAS DISEASE; CONGESTIVE CARDIOMYOPATHY; DIABETES MELLITUS; DNA POLYMORPHISM; FEMALE; GENE DELETION; GENOTYPE; HEART FAILURE; HEART LEFT VENTRICLE CONTRACTION; HEART VENTRICLE SIZE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MORTALITY; NONBIOLOGICAL MODEL; PRIORITY JOURNAL; STATISTICAL ANALYSIS; STUDENT T TEST; SURVIVAL RATE;

EID: 13844312024     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2003.12.026     Document Type: Article

References (32)

1. Cambien F., Alhenc-Gelas F., Herbeth B., Andre J.L., Rakotovao R., Gonzales M.F., et al. Familial resemblance of plasma angiotensin-converting enzyme level: the Nancy study. Am. J. Hum. Genet. 43:1988;774-780
2. Tiret L., Rigat B., Visvikis S., Breda C., Corvol P., Cambien F., et al. Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am. J. Hum. Genet. 51:1992;197-205
3. Rigat B., Hubert C., Alhenc-Gelas F., Cambien F., Corvol P., Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting gene accounting for half the variance of serum enzyme levels. J. Clin. Invest. 86:1990;1343-1346
4. Rigat B., Hubert C., Corvol P., Soubrier F. PCR detection of the insertion/deletion polymorphism of the human angiotensin-converting enzyme gene (DCP1) (dipeptidylcarboxypeptidase 1). Nucleic Acids Res. 20:1992;1433
5. Okamura T., Miyazaki M., Inagami T., Toda N. Vascular renin-angiotensin system in two-kidney, one clip hypertensive rats. Hypertension. 8:1986;560-565
6. Schunkert H., Jackson B., Tang S.S., Schoen F.J., Smits J.F.M., Apstein C.S., et al. Distribution and functional significance of cardiac angiotensin converting enzyme in hypertrophied rat hearts. Circulation. 87:1993;1328-1339
7. Lindpainter K., Ganten D. The cardiac renin-angiotensin system: a synopsis of current experimental and clinical data. Acta Cardiol. 46:1991;385-397
8. Raynolds M.V., Bristow M.R., Bush E.W., Abraham W.T., Lowes B.D., Zisman L.S., et al. Angiotensin-converting enzyme DD genotype in patients with ischaemic or idiopathic dilated cardiomyopathy. Lancet. 342:1993;1073-1075
9. Ohmichi N., Iwai N., Nakamura Y., Kinoshita M. The genotype of the angiotensin-converting enzyme gene and global left ventricular dysfuncyion after myocardial infarction. Am. J. Cardiol. 76:1995;326-329
10. Fernandez-Sola J., Nicolas J.M., Oriola J., Sacanella E., Estruch R., Rubin E., et al. Angiotensin-converting enzyme gene polymorphism is associated with vulnerability to alcoholic cardiomyopathy. Ann. Intern. Med. 137:2002;321-326
11. Andersson B., Sylvén C. The DD genotype of the angiotensin-converting enzyme gene is associated with increased mortality in idiopathic heart failure. J. Am. Coll. Cardiol. 28:1996;162-167
12. McNamara D.M., Holubkov R., Janosko K., Palmer A., Wang J.J., MacGowan G.A., et al. Pharmacogenetic interactions between beta-blocker therapy and the angiotensin-converting enzyme deletion polymorphism in patients with congestive heart failure. Circulation. 103:2001;1644-1648
13. Montgomery H.E., Keeling P.J., Goldman J.H., Humphries S.E., Talmud P.J., Mckenna W.J. Lack of association between the insertion/deletion polymorphism of the angiotensin-converting enzyme gene and idiopathic dilated cardiomyopathy. J. Am. Coll. Cardiol. 25:1995;1627-1631
14. Sanderson J.E., Young R.P., Yu C.M., Chan S., Critchley J.A.J.H., Woo K.S. Lack of association between insertion/deletion polymorphism of the angiotensin-converting enzyme gene and end-stage heart failure due to ischemic or idiopathic dilated cardiomyopathy in the chinese. Am. J. Cardiol. 77:1996;1008-1010
15. Tiret L., Cambien F. Departure from Hardy-Weinberg equilibrium should be systematically tested in studies of association between genetic markers and disease. Circulation. 92:1995;3364-3365
16. Mckee P.A., Castelli W.P., Mcnamara P.M., Kannel W.B. The natural history of congestive heart failure: the Framingham study. N. Engl. J. Med. 285:1971;1441-1446
17. Report of the WHO/ISFC task force on the definition and classification of cardiomyopathies. Br. Heart J. 44:1980;672-673
18. Richardson P., Mckenna W., Bristow M., Maisch B., Mautner B., O'connel J., et al. Report of the 1995 World Health Organization Society and Federation of Cardiology task force on the definition and classification of cardiomyopathies. Circulation. 93:1996;841-842
19. Miller A.S., Dykes D.D., Polesky H.F. A single salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16:1988;1215
20. Shanmugam V., Sell K.W., Saha B.K. Mistyping ACE heterozygotes. PCR Methods Appl. 3:1993;120-121
21. Sahn D.J., De Maria A., Kisslo J., Weyman A. The committee on M-mode standardization of the American Society of Echocardiography. Circulation. 58:1978;1072-1083
22. Walton S. Radionuclide ventriculography. Murray I.P.C., Ell P.J. Nuclear medicine in clinical diagnosis and treatment. 1st ed.:1994;1069-1081 Livingstone, New York
23. Lindpainter K., Pfeffer M.A., Kreutz R., Stampfer M.J., Grodstein F., Lamotte F., et al. A prospective evaluation of an angiotensin-converting enzyme gene polymorphism and the risk of ischemic heart disease. N. Engl. J. Med. 332:1995;706-711
24. SAS Institute SAS/STAT® user's guide. Version 6. 1989;SAS Institute, Cary, NC
25. Danser A.H.J., Schalekamp M.A.D.H., Bax W.A., Brink A.M., Saxena P.R., Rieger G.A.J., et al. Angiotensin-converting enzyme in the human heart. Effect of the deletion/insertion polymorphism. Circulation. 92:1995;1387-1388
26. Candy G.P., Skudicky D., Mueller U.K., Woodiwiss A.J., Sliwa K., Luker F., et al. Association of left ventricular systolic performance and cavity size with angiotnsin-converting enzyme genotype in idiopathic dilated cardiomyopathy. Am. J. Cardiol. 83:1999;740-744
27. Ueda S., Elliot H.L., Morton J.J., Connell J.M.C. Enhanced pressor response to angiotensin I in normotensive men with the deletion genotype (DD) for angiotensin-converting enzyme. Hypertension. 25:1995;1266-1269
28. Gharavi A.G., Lipkowitz M.S., Diamond J.A., Jhang J.S., Phillips R.A. Deletion polymorphism of the angiotensin-converting enzyme gene is independently associated with left ventricular mass and geometric remodeling in systemic hypertension. Am. J. Cardiol. 77:1996;1315-1319
29. Dougherty A.H., Naccarelli G.V., Gray E.L., Hicks C.H., Goldstein R.A. Congestive heart failure with normal systolic function. Am. J. Cardiol. 54:1984;778-782
30. Sasaki M., Oki T., Iuchi A., Tabata T., Yamada H., Manabe K., et al. Relationship between the angiotensin converting enzime gene polymorphism and the effects of enalapril on left ventricular hypertrophy and impaired diastolic filling in essential hypertension: M-mode and pulsed Doppler echocardiographic studies. J. Hypertens. 14:1996;1403-1408
31. Daniel M.S., John B.K., Salim Y., Miguel A.Q., Bertram P., Dawn S., et al. Wilson, for the SOLVD investigators. Diabetes mellitus, a predictor of morbidity and mortality in the Studies of Left Ventricular Dysfunction (SOLVD) trials and registry. Am. J. Cardiol. 77:1996;1017-1020
32. Freitas HFG. Prognóstico em portadores de insuficiência cardíaca encaminhados para avaliação de tratamento cirúrgico [dissertation]. São Paulo (SP): São Paulo University;2002.